Homepage

Medifast, Inc.

MED NYSE Categories PDF
Consumer Cyclical · Personal Products & Services · United States · Updated May 11, 1:55pm
$12.60
Price
$140.1M
Market Cap
504
Employees
0.57
Beta
Daniel R. Chard
CEO
Business Description

Medifast, Inc., through its subsidiaries, manufactures and distributes weight loss, weight management, healthy living products, and other consumable health and nutritional products in the United States and the Asia-Pacific. The company offers bars, bites, pretzels, puffs, cereal crunch, drinks, hearty choices, oatmeal, pancakes, pudding, soft serves, shakes, smoothies, soft bakes, and soups under the OPTAVIA, Optimal Health by Take Shape for Life, and Flavors of Home brands. It markets its products through point-of-sale transactions over ecommerce platform. The company was founded in 1980 and is headquartered in Baltimore, Maryland.

Business History
Price Overview
Last updated: May 11, 2026 1:55pm (just now)
$12.60
+0.01 (+0.08%)
Day Range
$12.44 – $12.75
52-Week Range
$9.22 – $15.46
50-Day MA
$10.61
200-Day MA
$11.92
Volume
64,761.00
Analyst Price Targets
Low $12.00
Consensus $12.00
High $12.00
(6 analysts)
Share Structure
Outstanding 11,119,100.00
Float 8,456,769.00
Free Float 76.1%
Normal free float — 76.1% of shares trade freely, ~23.9% held by insiders/institutions
Healthy float typical of established companies. Good liquidity for entering and exiting positions without major price impact.
Small absolute float (8.5M shares) — even with a decent free float %, volume can be thin. Check average daily volume before sizing a position.
Price History (1 Year)
Revenue & Net Income Trend
The directional story — useful even when net income is negative.
Revenue
The top line — total sales before any costs or taxes are subtracted. A measure of how much business the company is doing.
Net Income
The bottom line — profit left after subtracting all expenses, interest, and taxes from revenue. Reflects accounting profitability, but includes non-cash items like depreciation, so it isn't the same as cash earned.
Operating Cash Flow
The real cash generated by the day-to-day business — selling products, paying suppliers, collecting from customers. Calculated from net income by adding back non-cash items and adjusting for timing (unpaid bills, unsold inventory). When OCF consistently lags net income, the reported profit may not be converting to real money.
Period Revenue Net Income Net Margin YoY/QoQ
Key Metrics
API Direct from provider CALC Derived from statements
P/E Ratio (Price per dollar of earnings)
CALC
Stock Price / EPS (Diluted)
-7.41
Stock Price: $12.60
EPS (Diluted): -1.70
P/B Ratio (Price vs net asset value)
API
Stock Price / Book Value Per Share
0.59
Stock Price: $12.60
Total Equity: $198.92M
Shares: 10,981,000
EV/EBITDA (Total value vs operating profit)
API
Enterprise Value / EBITDA
46.42
Market Cap: $140.10M
Total Debt: $10.69M
Cash: $89.30M
EBITDA: -$3.71M
Enterprise Value (Takeover price (cap + debt - cash))
API
Market Cap + Total Debt - Cash
$44.8M
Market Cap: $140.10M
Total Debt: $10.69M
Cash: $89.30M
Gross Margin (Revenue left after direct costs)
API
Gross Profit / Revenue
71.3%
Gross Profit: $275.19M
Revenue: $385.79M
Operating Margin (Revenue left after all operations)
API
Operating Income / Revenue
-3.7%
Operating Income: -$14.21M
Revenue: $385.79M
Net Margin (Revenue left as actual profit)
API
Net Income / Revenue
-4.8%
Net Income: -$18.67M
Revenue: $385.79M
ROE (Profit from shareholder equity)
API
Net Income / Total Equity
-9.7%
Net Income: -$18.67M
Total Equity: $198.92M
ROIC (Profit from all invested capital)
API
NOPAT / Invested Capital
-6.6%
Operating Income: -$14.21M
Tax Rate: -231.1%
Equity: $198.92M
Total Debt: $10.69M
Cash: $89.30M
Current Ratio (Can it pay short-term bills)
API
Current Assets / Current Liabilities
4.69
Current Assets: $201.68M
Current Liabilities: $42.96M
Debt/Equity (Leverage — debt vs equity)
CALC
Total Debt / Total Equity
0.05
Short-Term Debt: $4.60M
Long-Term Debt: $6.09M
Total Debt: $10.69M
Total Equity: $198.92M
Rev/Share (Top-line per share)
CALC
Revenue / Shares Outstanding
$35.13
Revenue: $385.79M
Shares: 10,981,000
Book Value/Share (Net assets per share)
CALC
(Total Assets - Total Liabilities) / Shares
$18.11
Total Equity: $198.92M
Shares: 10,981,000
FCF/Share (Real cash generated per share)
CALC
(Operating Cash Flow + CapEx) / Shares
$0.11
Operating CF: $6.86M
CapEx: -$5.61M
Shares: 10,981,000
CapEx is negative (outflow) — added to OCF to get FCF
Div Yield (Annual income from holding)
API
Last Annual Dividend / Stock Price
0.2%
Last Dividend: N/A
Stock Price: $12.60
Payout Ratio (Earnings paid out as dividends)
Dividends Paid / Net Income
—
Dividends Paid: N/A
Net Income: -$18.67M
Dividends paid not available in cash flow statement
Industry Benchmarks
Compares MED against LLM-researched typical ranges for its industry. One research call per industry, cached indefinitely — every stock in the same industry reuses the same baseline.
Deep Analysis

Pre-flight intelligence scans the company first, then routes to the right analytical methods.

0 Company Classification — What type of company is this?
1 Industry Landscape — Where is the industry headed?
2 Company Momentum — Where is this company trending?
3 Forward Projection — 1Y & 2Y projected metrics (requires Layer 1 + 2)
4a DCF Valuation — Present value of future cash flows
4b Earnings Power Value — Floor value — worth with zero growth
4c Anchored PE — Industry PE adjusted for growth differential
4d Reverse DCF — What growth is the market pricing in?
4e Revenue-Based DCF — For growth/narrative companies (skip if mature earner)
4f Anchored P/S — Price-to-Sales peer comparison (skip if mature earner)
4g Scenario Analysis — Bull / Base / Bear (skip if mature earner)
4h Dividend Discount Model — For dividend/income stocks only
4i Book Value Analysis — For deep value / turnaround stocks only
4j Insider Activity — Are insiders buying or selling?
4f Cash Flow Quality — How trustworthy is the FCF?
4g Debt Maturity Risk — Can it handle its debt?
4h Macro Environment — Rates, market valuation, volatility
4i Sector Intelligence — How does this company compare within its sector?
4j Revenue Confidence — How reliable is the growth projection?
4k Sensitivity Analysis — How fragile is the fair value estimate?
4l Sector Demand Cycle — Is the sector in a boom, steady state, or contraction?
5 AI Investigation — Adaptive research engine (Claude)
5b Thesis Evaluation — What does the market believe? (narrative/platform stocks only)
6 Valuation Synthesis — Weighted verdict from all methods (requires Layer 4)
Income Statement (Annual)
Metric 2021 2022 2023 2024 2025
Revenue $1.5B $1.6B $1.1B $602.5M $385.8M
Cost of Revenue $398.5M $458.2M $296.2M $157.8M $110.6M
Gross Profit $1.1B $1.1B $775.9M $444.6M $275.2M
Operating Expenses $911.4M $955.6M $649.4M $441.7M $289.4M
Operating Income $216.2M $184.8M $126.4M $2.9M -$14.2M
Net Income $164.0M $143.6M $99.4M $2.1M -$18.7M
EBITDA $223.1M $195.7M $139.5M $15.6M -$3.7M
EPS $14.01 $12.82 $9.10 $0.19 $-1.70
EPS (Diluted) — — — — —
Balance Sheet (Annual)
Metric 2021 2022 2023 2024 2025
Cash & Equivalents $104.2M $87.7M $94.4M $90.9M $89.3M
Total Current Assets $306.9M $222.8M $224.0M $214.4M $201.7M
Total Assets $398.3M $316.2M $309.9M $284.2M $257.0M
Current Liabilities $169.8M $140.9M $92.3M $64.2M $43.0M
Long-Term Debt $0 $0 $0 $0 $6.1M
Total Liabilities $195.9M $161.2M $108.4M $74.1M $58.1M
Total Equity $202.5M $155.0M $201.5M $210.1M $198.9M
Retained Earnings $190.3M $139.9M $174.6M $176.8M $158.3M
Cash Flow (Annual)
Metric 2021 2022 2023 2024 2025
Operating Cash Flow $94.5M $194.6M $147.7M $24.5M $6.9M
Capital Expenditure -$34.2M -$16.7M -$6.5M -$7.5M -$5.6M
Free Cash Flow $60.3M $177.9M $141.2M $17.0M $1.2M
Acquisitions (net) $0 $0 $0 $0 $0
Debt Repayment — — — — —
Dividends Paid — — — — —
Stock Buybacks -$62.1M -$128.0M -$7.0M $-836,000 $-369,000
Net Change in Cash -$59.5M -$16.5M $6.7M -$3.5M -$1.6M
Analyst Estimates (Annual)
Metric 2024 2025 2026 2027
Revenue $601.6M
$601.6M – $601.6M
 $382.1M
$382.1M – $382.1M
 $279.7M
$279.7M – $279.7M
 $256.0M
$256.0M – $256.0M
EBITDA $49.9M
$49.9M – $49.9M
 $31.7M
$31.7M – $31.7M
 $23.2M
$23.2M – $23.2M
 $21.2M
$21.2M – $21.2M
Net Income $19.4M
$17.5M – $21.3M
 -$12.3M
-$12.3M – -$12.3M
 -$20.3M
-$20.3M – -$20.3M
 -$6.6M
-$6.6M – -$6.6M
EPS — — — —
Growth Trends (YoY %)
Metric 2022 2023 2024 2025
Revenue Growth +4.8% -32.9% -43.8% -36.0%
Gross Profit Growth +1.1% -32.0% -42.7% -38.1%
Operating Income Growth -14.5% -31.6% -97.7% -593.8%
Net Income Growth -12.5% -30.8% -97.9% -993.0%
EBITDA Growth -12.2% -28.7% -88.8% -123.8%
Insider Trading (Recent)
Date Insider Type Shares Price Value
2026-01-05 Johnson Nicholas Mark 0.00 $0.00 $0
2026-01-05 Johnson Nicholas Mark 0.00 $0.00 $0
2026-01-05 Johnson Nicholas Mark 0.00 $0.00 $0
2026-01-05 Johnson Nicholas Mark 0.00 $0.00 $0
2023-02-07 Johnson Nicholas Mark 22,640.00 $66.68 $1.5M
2026-03-25 MacKenzie Jonathan Barrett A-Award 10,830.00 $0.00 $0
2026-03-13 MacKenzie Jonathan Barrett F-InKind 198.00 $9.62 $1,905
2026-03-17 MacKenzie Jonathan Barrett F-InKind 70.00 $10.05 $704
2026-03-25 MacKenzie Jonathan Barrett F-InKind 862.00 $9.59 $8,267
2026-03-25 Maloney James P. A-Award 1,014.00 $0.00 $0
2026-03-25 Maloney James P. A-Award 34,344.00 $0.00 $0
2026-03-13 Maloney James P. F-InKind 918.00 $9.62 $8,831
2026-03-17 Maloney James P. F-InKind 482.00 $10.05 $4,844
2026-03-25 Maloney James P. F-InKind 3,224.00 $9.59 $30,918
2026-03-25 Chard Daniel R A-Award 4,827.00 $0.00 $0
2026-03-25 Chard Daniel R A-Award 36,968.00 $0.00 $0
2026-03-13 Chard Daniel R F-InKind 7,075.00 $9.62 $68,062
2026-03-17 Chard Daniel R F-InKind 2,638.00 $10.05 $26,512
2026-03-25 Chard Daniel R F-InKind 20,095.00 $9.59 $192,711
2026-03-20 Chard Daniel R P-Purchase 17,678.00 $10.11 $178,725
Dividend History (Last 20)
Date Dividend Declaration Record Payment
2023-09-18 $1.65 2023-09-07 2023-09-19 2023-11-07
2023-06-26 $1.65 2023-06-15 2023-06-27 2023-08-08
2023-03-27 $1.65 2023-03-16 2023-03-28 2023-05-09
2022-12-19 $1.64 2022-12-08 2022-12-20 2023-02-07
2022-09-19 $1.64 2022-09-08 2022-09-20 2022-11-08
2022-06-27 $1.64 2022-06-16 2022-06-28 2022-08-08
2022-03-28 $1.64 2022-03-17 2022-03-29 2022-05-09
2021-12-20 $1.42 2021-12-08 2021-12-21 2022-02-08
2021-09-20 $1.42 2021-09-09 2021-09-21 2021-11-08
2021-06-21 $1.42 2021-06-03 2021-06-22 2021-08-06
2021-03-29 $1.42 2021-03-18 2021-03-30 2021-05-06
2020-12-21 $1.13 2020-12-10 2020-12-22 2021-02-05
2020-09-21 $1.13 2020-09-10 2020-09-22 2020-11-06
2020-06-29 $1.13 2020-06-16 2020-06-30 2020-08-06
2020-03-30 $1.13 2020-03-19 2020-03-31 2020-05-06
2019-12-26 $1.13 2019-12-03 2019-12-27 2020-02-06
2019-09-26 $0.75 2019-09-12 2019-09-27 2019-11-07
2019-06-27 $0.75 2019-06-13 2019-06-28 2019-08-07
2019-03-28 $0.75 2019-03-13 2019-03-29 2019-05-07
2018-12-20 $0.75 2018-12-11 2018-12-21 2019-02-07
Community AI Feedback
Sign in to Contribute
No community reviews yet for MED. Be the first — export the analysis to your AI and contribute back.
My Notes personal — only you see this
Data via Financial Modeling Prep · Cached for performance · fmp
v1.1.193 · 1946f027 · 2026-05-08 18:57:27